TLR4 and TLR9 are induced in oral lichen planus

Journal of Oral Pathology and Medicine

Volumn 41, Issue 10, 2012, Pages 741-747

  Siponen, Maria ^a   Kauppila, Joonas H ^b   Soini, Ylermi ^a   Salo, Tuula ^b,c  

^a KUOPIO UNIVERSITY HOSPITAL   (Finland)

^b UNIVERSITY OF OULU   (Finland)

^c UNIVERSITY OF HELSINKI   (Finland)

Author keywords

Oral lichen planus; TLR4; TLR9; Toll like receptor

Indexed keywords

TACROLIMUS; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR 9;

ARTICLE; BASEMENT MEMBRANE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE COURSE; DRUG EFFECT; ERYTHEMA; HUMAN; IMMUNOHISTOCHEMISTRY; LICHEN PLANUS; MOUTH MUCOSA; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION;

ADMINISTRATION, TOPICAL; CASE-CONTROL STUDIES; HUMANS; IMMUNOHISTOCHEMISTRY; IMMUNOSUPPRESSIVE AGENTS; LICHEN PLANUS, ORAL; MOUTH MUCOSA; REFERENCE VALUES; TACROLIMUS; TOLL-LIKE RECEPTOR 4; TOLL-LIKE RECEPTOR 9;

EID: 84868371037     PISSN: 09042512     EISSN: 16000714     Source Type: Journal    
DOI: 10.1111/j.1600-0714.2012.01169.x     Document Type: Article

References (41)

1. Kawai T, Akira S. The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors. Nat Immunol 2010; 11: 373-84.
2. Ospelt C, Gay S. TLRs and chronic inflammation. Int J Biochem Cell Biol 2010; 42: 495-505.
3. Miyake K. Innate immune sensing of pathogens and danger signals by cell surface Toll-like receptors. Semin Immun 2007; 19: 3-10.
4. Chen K, Huang J, Gong W, Iribarren P, Dunlop NM, Wang JM. Toll-like receptors in inflammation, infection and cancer. Int Immunopharmacol 2007; 7: 1271-85.
5. Richez C, Blanco P, Rifkin I, Moreau JF, Schaeverbeke T. Role of toll-like receptors in autoimmune disease: the example of systemic lupus erythematosus. Joint Bone Spine 2011; 78: 124-30.
6. Mori Y, Yoshimura A, Ukai T, Lien E, Espevik T, Hara Y. Immunohistochemical localization of Toll-like receptors 2 and 4 in gingival tissue from patients with periodontitis. Oral Microbiol Immunol 2003; 18: 54-8.
7. Ren L, Leung WK, Darveau RP, Jin L. The expression profile of lipopolysaccharide-binding protein, membrane-bound CD14, and toll-like receptors 2 and 4 in chronic periodontitis. J Periodontol 2005; 76: 1950-9.
8. Sugawara Y, Uehara A, Fujimoto Y, et al. Toll-like receptors, NOD1, and NOD2 in oral epithelial cells. J Dent Res 2006; 85: 524-9.
9. Mahanonda R, Pichyangkul S. Toll-like receptors and their role in periodontal health and disease. Periodontol 2000 2007; 43: 41-55.
10. Beklen A, Hukkanen M, Richardson R, Konttinen YT. Immunohistochemical localization of Toll-like receptors 1-10 in periodontitis. Oral Microbiol Immunol 2008; 23: 425-31.
11. Rojo-Botello NR, García-Hernández AL, Moreno-Fierros L. Expression of toll-like receptors 2, 4 and 9 is increased in gingival tissue from patients with type 2 diabetes and chronic periodontitis. J Periodontal Res 2012; 47: 62-73.
12. Uehara A, Sugawara S, Tamai R, Takada H. Contrasting responses of human gingival and colonic epithelial cells to lipopolysaccharides, lipoteichoic acids and peptidoglycans in the presence of soluble CD14. Med Microbiol Immunol 2001; 189: 185-92.
13. Uehara A, Fujimoto Y, Fukase K, Takada H. Various human epithelial cells express functional Toll-like receptors, NOD1 and NOD2 to produce anti-microbial peptides, but not proinflammatory cytokines. Mol Immunol 2007; 44: 3100-11.
14. Kim Y, Jo AR, Jang DH, et al. Toll-like receptor 9 mediates oral bacteria-induced IL-8 expression in gingival epithelial cells. Immunol Cell Biol 2011; In press.
15. Ali A, Natah S, Konttinen Y. Differential expression of Toll-like receptors in chronic hyperplastic candidosis. Oral Microbiol Immunol 2008; 23: 299-307.
16. Szczepanski MJ, Czystowska M, Szajnik M, et al. Triggering of Toll-like receptor 4 expressed on human head and neck squamous cell carcinoma promotes tumor development and protects the tumor from immune attack. Cancer Res 2009; 69: 3105-13.
17. Jukkola-Vuorinen A, Rahko E, Vuopala KS, et al. Toll-like receptor-9 expression is inversely correlated with estrogen receptor status in breast cancer. J Innate Immun 2009; 1: 59-68.
18. Väisänen MR, Väisänen T, Jukkola-Vuorinen A, et al. Expression of toll-like receptor-9 is increased in poorly differentiated prostate tumors. Prostate 2010; 70: 817-24.
19. Takala H, Kauppila JH, Soini Y, et al. Toll-like receptor 9 is a novel biomarker for esophageal squamous cell dysplasia and squamous cell carcinoma progression. J Innate Immun 2011; 3: 631-8.
20. Park JH, Yoon HE, Jeon DI, Ahn SG, Yoon JH. Activation of TLR2 and TLR5 did not affect tumor progression of an oral squamous cell carcinoma, YD-10B cells. J Oral Pathol Med 2010; 39: 781-5.
21. Roopashree MR, Gondhalekar RV, Shashikanth MC, George J, Thippeswamy SH, Shukla A. Pathogenesis of oral lichen planus - a review. J Oral Pathol Med 2010; 39: 729-34.
22. Li J, Chen J, Tan Z, Liu H, Liu Z. Expression of TLR9 and its mRNA in the lesions of lichen planus. J Huazhong Univ Sci Technolog Med Sci 2007; 27: 203-5.
23. Ohno S, Tateishi Y, Tatemoto Y, Morishita K, Sasabe E, Yamamoto T. Enhanced expression of Toll-like receptor 2 in lesional tissues and peripheral blood monocytes of patients with oral lichen planus. J Dermatol 2011; 38: 335-44.
24. Janardhanam SB, Prakasam S, Swaminathan VT, Kodumudi KN, Zunt SL, Shrinivasan M. Differential expression of TLR-2 and TLR-4 in the epithelial cells in oral lichen planus. Arch Oral Biol 2012; 57: 495-502.
25. Zunt SL, Burton LV, Goldblatt LI, Dobbins EE, Srinivasan M. Soluble forms of Toll-like receptor 4 are present in human saliva and modulate tumour necrosis factor-alpha secretion by macrophage-like cells. Clin Exp Immunol 2009; 156: 285-93.
26. Al Johani KA, Hegarty AM, Porter SR, Fedele S. Calcineurin inhibitors in oral medicine. J Am Acad Dermatol 2009; 61: 829-40.
27. López-Jornet P, Camacho-Alonso F, Salazar-Sanchez N. Topical tacrolimus and pimecrolimus in the treatment of oral lichen planus: an update. J Oral Pathol Med 2010; 39: 201-5.
28. Kis K, Bodai L, Polyanka H, et al. Budesonide, but not tacrolimus, affects the immune functions of normal human keratinocytes. Int Immunopharmacol 2006; 6: 358-68.
29. Antiga E, Volpi W, Torchia D, Fabbri P, Caproni M. Effects of tacrolimus ointment on Toll-like receptors in atopic dermatitis. Clin Exp Dermatol 2011; 36: 235-41.
30. Garantziotis S, Hollingsworth JW, Zaas AK, Schwartz DA. The effect of toll-like receptors and toll-like receptor genetics in human disease. Annu Rev Med 2008; 59: 343-59.
31. Miller LS, Modlin RL. Toll-like receptors in the skin. Semin Immunopathol 2007; 29: 15-26.
32. Ermertcan AT, Öztürk F, Gündüz K. Toll-like receptors and skin. J Eur Acad Dermatol Venereol 2011; 25: 997-1006.
33. Ramanathan M Jr, Lee WK, Dubin MG, Lin S, Spannhake EW, Lane AP. Sinonasal epithelial cell expression of toll-like receptor 9 is decreased in chronic rhinosinusitis with polyps. Am J Rhinol 2007; 21: 110-6.
34. Gallo C, Barros F, Sugaya N, Nunes F, Borra R. Differential expression of toll-like receptor mRNAs in recurrent aphthous ulceration. J Oral Pathol Med 2012; 41: 80-5.
35. Hietanen J, Häyrinen-Immonen R, Al-Samadi A, Trokovic N, Koskenpato K, Konttinen YT. Recurrent aphthous ulcers-a Toll-like receptor-mediated disease? J Oral Pathol Med 2012; 41: 158-64.
36. Kawai T, Akira S. Toll-like receptors and their crosstalk with other innate receptors in infection and immunity. Immunity 2011; 34: 637-50.
37. Kikkert R, Laine ML, Aarden LA, van Winkelhoff AJ. Activation of toll-like receptors 2 and 4 by gram-negative periodontal bacteria. Oral Microbiol Immunol 2007; 22: 145-51.
38. Bornstein MM, Hakimi B, Persson GR. Microbiological findings in subjects with asymptomatic oral lichen planus: a cross-sectional comparative study. J Periodontol 2008; 79: 2347-55.
39. Syrjänen S, Lodi G, von Bültzingslöwen I, et al. Human papillomaviruses in oral carcinoma and oral potentially malignant disorders: a systematic review. Oral Dis 2011; 17(Suppl. 1): 58-72.
40. Abiko Y, Jinbu Y, Noguchi T, et al. Upregulation of human beta-defensin 2 peptide expression in oral lichen planus, leukoplakia and candidiasis. An immunohistochemical study. Pathol Res Pract 2002; 198: 537-42.
41. Miller LS, Sørensen OE, Liu PT, et al. TGF-alpha regulates TLR expression and function on epidermal keratinocytes. J Immunol 2005; 174: 6137-43.